Showing 4,001 - 4,020 results of 5,085 for search '"cardiovascular"', query time: 0.07s Refine Results
  1. 4001

    Myocardial Perfusion and Function Are Distinctly Altered by Sevoflurane Anesthesia in Diet-Induced Prediabetic Rats by Charissa E. van den Brom, Chantal A. Boly, Carolien S. E. Bulte, Rob F. P. van den Akker, Rick F. J. Kwekkeboom, Stephan A. Loer, Christa Boer, R. Arthur Bouwman

    Published 2016-01-01
    “…Volatile anesthetics, like sevoflurane, have cardiodepressive effects and may aggravate cardiovascular complications. We investigated the effect of sevoflurane on myocardial perfusion and function in prediabetic rats. …”
    Get full text
    Article
  2. 4002

    Inflammatory Mechanisms Associated with Skeletal Muscle Sequelae after Stroke: Role of Physical Exercise by Hélio José Coelho Junior, Bruno Bavaresco Gambassi, Tiego Aparecido Diniz, Isabela Maia da Cruz Fernandes, Érico Chagas Caperuto, Marco Carlos Uchida, Fabio Santos Lira, Bruno Rodrigues

    Published 2016-01-01
    “…Besides being associated with cardiovascular risk factors, proinflammatory cytokines seem to play a key role in muscle atrophy by regulating the pathways involved in this condition. …”
    Get full text
    Article
  3. 4003

    Evaluation of Arterial Stiffness Using Pulse Wave Velocity and Augmentation Index in Patients with Chronic Venous Insufficiency by Mustafa Dogdus, Onur Akhan, Mehmet Ozyasar, Ahmet Yilmaz, Mehmet Sait Altintas

    Published 2018-01-01
    “…Arterial stiffness has been shown to be a predictor of cardiovascular events and mortality. The relationship between CVI and arterial stiffness using pulse wave velocity (PWV) and augmentation index (Aix) was evaluated in this study. …”
    Get full text
    Article
  4. 4004

    Optimización SGLT2 para cardionefro protección by Yukiko Harumi Yamasaki Ramos, Marbella Haddad Toledo

    Published 2025-01-01
    “…Los inhibidores del cotransportador de sodio-glucosa tipo 2 (SGLT2) no solo regulan los niveles de glucosa en la diabetes tipo 2, sino que también ofrecen protección renal y cardiovascular. Contribuyen a la reducción de eventos cardiovasculares y la progresión de enfermedades renales al disminuir la presión arterial, la carga de glucosa y el estrés oxidativo, además de mejorar la función cardiaca. …”
    Get full text
    Article
  5. 4005

    Impact of Patient Beliefs on Blood Pressure Control in the General Population: Findings from the Population-Based STAAB Cohort Study by Theresa Tiffe, Caroline Morbach, Viktoria Rücker, Götz Gelbrich, Martin Wagner, Hermann Faller, Stefan Störk, Peter U. Heuschmann

    Published 2019-01-01
    “…The Beliefs about Medicines Questionnaire German Version (BMQ-D) was provided in a subsample without established cardiovascular diseases (CVD) treated for hypertension. …”
    Get full text
    Article
  6. 4006

    Prematurity-Related Hypertension in Children and Adolescents by Karolina Poplawska, Karolina Dudek, Maja Koziarz, Dominik Cieniawski, Tomasz Drozdz, Sylwester Smialek, Dorota Drozdz, Przemko Kwinta

    Published 2012-01-01
    “…Moreover, pediatric hypertension is a significant problem, because of its transformation into adult hypertension and increased cardiovascular risk later in life. Therefore it is crucial to introduce wide-spread screening and detection of elevated blood pressure, especially among prematurely born children.…”
    Get full text
    Article
  7. 4007
  8. 4008

    Effects on Serum Fractalkine by Diet and Omega-3 Fatty Acid Intervention: Relation to Clinical Outcome by Kristian Laake, Ingebjørg Seljeflot, Morten Wang Fagerland, Ida Unhammer Njerve, Harald Arnesen, Svein Solheim

    Published 2015-01-01
    “…We have investigated the effect of Mediterranean-like dietary counseling and n-3 PUFA on serum fractalkine in an elderly population and its ability to predict cardiovascular disease (CVD). Materials and Methods. 563 men (age 64–75 yrs) at high risk of CAD were randomized into a 2 × 2 factorial designed trial for 3-year dietary counseling and/or n-3 PUFA supplementation (2.4 g/d). …”
    Get full text
    Article
  9. 4009
  10. 4010

    A Fast and Validated HPLC Method for Simultaneous Determination of Dopamine, Dobutamine, Phentolamine, Furosemide, and Aminophylline in Infusion Samples and Injection Formulations by Fuchao Chen, Baoxia Fang, Sicen Wang

    Published 2021-01-01
    “…A simple, fast, and validated HPLC method was developed for the simultaneous quantization of five cardiovascular agents: dopamine (DPM), dobutamine (DBM), phentolamine (PTM), furosemide (FSM), and aminophylline (APL) either in infusion samples or in an injection dosage form. …”
    Get full text
    Article
  11. 4011

    Use of Drugs Associated with QT Interval Prolongation at the Hospital Level during the COVID-19 Pandemic in Colombia by Andrés Gaviria-Mendoza, Manuel Enrique Machado-Duque, Luis Fernando Valladales-Restrepo, Carlos Fernando Tovar-Yepes, Jorge Enrique Machado-Alba

    Published 2022-01-01
    “…The most commonly used belonged to the group of drugs for the nervous system (63.0%), alimentary tract and metabolism (56.8%), anti-infectives for systemic use (13.0%), and the cardiovascular system (11.7%). On average, patients received 2.0±1.5 risk drugs. …”
    Get full text
    Article
  12. 4012

    Korelasi Kadar Adiponektin dengan Kadar Kolesterol High Density Lipoprotein pada Penyandang Obes by Fiona Septi Mulya, Efrida Efrida, Zelly Dia Rofinda

    Published 2022-01-01
    “…Adiponectin and HDL cholesterol have a protective cardiovascular effect. Adiponectin levels decrease in obese people. …”
    Get full text
    Article
  13. 4013
  14. 4014

    Effects of Dietary Strawberry Supplementation on Antioxidant Biomarkers in Obese Adults with Above Optimal Serum Lipids by Arpita Basu, Stacy Morris, Angel Nguyen, Nancy M. Betts, Dongxu Fu, Timothy J. Lyons

    Published 2016-01-01
    “…Berries have shown several cardiovascular health benefits and have been associated with antioxidant functions in experimental models. …”
    Get full text
    Article
  15. 4015

    Boosting Therapeutic Effect of Turmeric, Coffee, and Chili Extracts Through Experimental Design and Encapsulation as Nanostructured Lipid Carriers for Novel Heath Supplements by Pratchaya Tipduangta, Phennapha Saokham, Jutamas Jiaranaikulwanitch, Siriporn Okonogi, Chadarat Ampasavate, Kanokwan Kiattisin

    Published 2025-01-01
    “…This study investigates the potential synergistic effects of extracts from <i>Curcuma longa</i> (turmeric), <i>Coffea arabica</i> (Arabica coffee beans), and <i>Capsicum annuum</i> (chili peppers) in reducing oxidative stress and inflammation, which are associated with metabolic disorders such as obesity, diabetes, and cardiovascular diseases. Using a systematic design of experiment (DoE) optimization approach, an optimal extract ratio of 1:3:4 (turmeric: coffee: chili) was identified. …”
    Get full text
    Article
  16. 4016

    Hyperlactatemia and the Outcome of Type 2 Diabetic Patients Suffering Acute Myocardial Infarction by Jovanovic Aleksandar, Peric Vladan, Snezana Markovic-Jovanovic, Radojica Stolic, Jadranka Mitic, Tanja Smilic

    Published 2016-01-01
    “…Three groups, each consisting of 40 patients (type 2 diabetics with myocardial infarction, DM+AMI, nondiabetics suffering myocardial infarction, MI, and diabetics with no apparent cardiovascular pathology, DM group), were tested for pH, serum bicarbonate and electrolytes, blood lactate, and CK-MB. …”
    Get full text
    Article
  17. 4017

    Maternal Fructose Intake Induces Insulin Resistance and Oxidative Stress in Male, but Not Female, Offspring by Lourdes Rodríguez, Paola Otero, María I. Panadero, Silvia Rodrigo, Juan J. Álvarez-Millán, Carlos Bocos

    Published 2015-01-01
    “…Fructose intake from added sugars correlates with the epidemic rise in metabolic syndrome and cardiovascular diseases. However, consumption of beverages containing fructose is allowed during gestation. …”
    Get full text
    Article
  18. 4018

    Assessing the health and economic burden of obesity-related complications in East-Asian populations: implementation of risk equations in the Core Obesity Model for Japan and model... by Ichiro Tatsuno, Mark Lamotte, Laetitia Gerlier, Anamaria-Vera Olivieri, James Baker-Knight

    Published 2024-04-01
    “…Internal and external validation were performed.Results Overall, good internal validity was achieved, with mild underestimation for diabetes, cardiovascular and all-cause death taken together (ordinary least squares linear regression [OLS-LRL] 0.8844), moderate overestimation of TKR and cancers (OLS-LRL 1.267) and a slight underestimation for NAFLD and hyperuricaemia (OLS-LRL 0.934). …”
    Get full text
    Article
  19. 4019

    The influence of the pharmacodynamic properties of drugs on indications for their use: Sodium-glucose cotransporter 2 inhibitors (SGLT2 inhibitors) by Denda Nikola I., Maletin Nemanja Z., Atanasković Marko B., Vučković Biljana A., Rašković Aleksandar L.

    Published 2024-01-01
    “…Introduction: Sodium-glucose cotransporter type 2 (SGLT2) inhibitors play a crucial role in type 2 diabetes treatment, exerting effects on proximal tubules to reduce glucose reab-sorption and enhance urinary excretion, offering cardiovascular and renoprotective benefits. This study aims to explore the pharmacodynamic advantages of SGLT2 inhibitors, expanding their therapeutic indications and assessing variations in pharmacological effects among different representatives. …”
    Get full text
    Article
  20. 4020

    Exendin-4 Protects against Hyperglycemia-Induced Cardiomyocyte Pyroptosis via the AMPK-TXNIP Pathway by Hong Wei, Rui Bu, Qinghui Yang, Jing Jia, Tao Li, Qiuping Wang, Yanjun Chen

    Published 2019-01-01
    “…Exendin-4, a GLP analog, promotes survival of cardiomyocytes in cardiovascular diseases, including diabetic cardiomyopathy. …”
    Get full text
    Article